Transcatheter Mitral Valve Repair & Replacement Market By Product (Mechanical Valves, Bioprosthetic Tissue (Biological) Valves), By Indications (Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation): Global Opportunity Analysis and Industry Forecast, 2020-2030

Transcatheter Mitral Valve Repair & Replacement Market

Mitral valve, also known as the bicuspid valve or left atrioventricular valve, which is located between the left atrium and the left ventricle of the heart. Mitral valve repair or replacement is necessary when the blood starts flowing backward, which occurs due to narrowing of the valve or due heart associated infections such as endocarditis. Two types of mitral valves are available for replacement—mechanical and bioprosthetic valves. Mechanical valves are made of materials such as carbon and titanium, whereas bioprosthetic valves are made from tissues of animals such as pig and cows. Transcatheter Mitral Valve Repair & Replacement Market is a minimally invasive technique for the treatment of heart-associated diseases such as mitral valve stenosis, mitral valve prolapses, and mitral valve regurgitation, also such minimally invasive procedures, which have certain benefits such as shorter recovery time, less stay in hospitals, less pain, fewer wound complications, and better wound cosmesis. In minimally invasive surgeries, a surgeon generally makes a 5cm cut on the right side of the chest and gently opens up the space between ribs to gain entry to the heart. Further, a high definition video camera is used to guide the procedure inside the heart and then the procedure is continued for mitral valve repair or replacement. Therefore, due to the various advantages mentioned above of minimally invasive mitral valve surgeries, most of the surgeon’s advice the patients to opt for transcatheter mitral valve surgeries which further supplement the growth of transcatheter mitral valve repair and replacement market.

Increase in incidence of heart diseases especially among the geriatric population, technological advancements, and introduction of novel mitral valves are expected to drive the TMVR Market growth However, implementation of stringent regulations by governing bodies for approval of novel mitral valve stents as well as lack of awareness among healthcare professionals impede the growth of TMVR Market Size. Conversely, continuous product innovations and introduction of novel mitral valves in untapped economies are anticipated to create lucrative opportunities for key market players.

On the basis of product in TMVR Market Share, the transcatheter mitral valve repair and replacement market is categorized as mechanical valves and bioprosthetic tissue (biological) valves. The mechanical valves segment is expected to dominate the market throughout the TMVR Market Analysis period, owing  to rise in geriatric population and increase in incidences of heart valve disorders. In addition, varied benefits associated with mechanical mitral valves such as increased durability and lower complication as compared to bioprosthetic valves boost the market growth. The bioprosthetic tissue (biological) valves segment is expected to register a CAGR of 14.3% during the TMVR Market Forecast period, owing to the need for bio compatible mitral valves for the geriatric population for reducing the complications caused post surgery.

On the basis of indication, the mitral valve regurgitation segment accounted for a major share of the market share in the transcatheter mitral valve repair and replacement market in 2020. This segment is expected to exhibit a prominent growth rate, owing due to the prevalence of mitral valve regurgitation and sudden deaths, which are responsible for approximately a quarter of the deaths occurring under medical treatment.

North America in TMVR Industry, accounted for more than 14.6% of the global market share in 2020, and is expected to remain dominant throughout the forecast period, owing to rise in number of high-risk or inoperable severe mitral stenosis patients in the region. In addition, sophisticated healthcare infrastructure, increased awareness among cardiologists, and patients for transcatheter mitral valve repair and replacement are set to boost the market growth. Asia-Pacific is projected to register the highest CAGR of 16.0% during the forecast period, the prevalence of mitral valve diseases and deaths caused owing to this disease are the key reasons that increase the growth of this market.

The major companies profiled in the report of TMVR Industry include in LivaNova Plc., Abbott Laboratories, Biotronik Pvt., Ltd., Edward Lifesciences, Medtronic Plc., Neovasc Inc., NeoChord, St. Jude Medical, Direct Flow Medical Inc., and Colibri Heart Valve, LLC.

KEY FINDINGS OF THE STUDY

The mechanical valves segment accounted for 15.2% of the global market in 2020.

The mitral valve regurgitation segment accounted for 16.7% share of the market in 2020.

U.S. was the major shareholder in the North America transcatheter mitral valve repair & replacement market, and accounted for the highest share in 2020

Asia-Pacific is expected to register the highest CAGR of 16.0% during the forecast period.

Overview

Transcatheter mitral valve repair and replacement is a minimally invasive technique for the treatment of heart-associated diseases such as mitral valve stenosis, mitral valve prolapses, and mitral valve regurgitation. In case of mitral valve misfunctioning, an individual can experience symptom such as fatigue and shortness of breath. Mitral valve diseases occurs when mitral valve does not pump enough blood out of the left ventricular chamber to supply the body with oxygen-filled blood. Mitral valve disorders are severe, if untreated, they may lead to heart failure and irregular heartbeats called arrhythmias.

The major factors that drive the growth of the global transcatheter mitral valve repair and replacement market include increase in incidence of heart diseases especially among the geriatric population, technological advancements, and introduction of novel mitral valves. However, implementation of stringent regulations by governing bodies for the approval of novel mitral valve stents, high cost of mitral valve surgeries, and risks associated with this procedure restrain the market growth. Conversely, continuous product innovations and introduction of novel mitral valves in untapped economies are anticipated to create lucrative opportunities for key market players.

The global transcatheter mitral valve repair and replacement market is segmented into product, indication, and region. According to product, the market is divided into mechanical valves and bioprosthetic tissue (biological) valves. By indication, it is categorized into mitral valve stenosis, mitral valve prolapses, and mitral valve regurgitation. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include LivaNova Plc., Abbott Laboratories, Biotronik Pvt., Ltd., Edward Lifesciences, Medtronic Plc., Neovasc Inc., NeoChord, St. Jude Medical, Direct Flow Medical Inc., and Colibri Heart Valve, LLC.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the transcatheter mitral valve repair & replacement market analysis from 2020 to 2030 to identify the prevailing transcatheter mitral valve repair & replacement market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the transcatheter mitral valve repair & replacement market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global transcatheter mitral valve repair & replacement market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

CORAMAZE TECHNOLOGIES GMBH

Scope of Transcatheter Mitral Valve Repair & Replacement Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Mechanical Valves

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Bioprosthetic Tissue (Biological) Valves

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Mitral Valve Stenosis

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Mitral Valve Prolapse

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

5.4 Mitral Valve Regurgitation

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key trends and opportunities

6.2.2 North America Market size and forecast, by By Product

6.2.3 North America Market size and forecast, by By Indications

6.2.4 North America Market size and forecast, by country

6.2.4.1 U.S.

6.2.4.1.1 Market size and forecast, by By Product

6.2.4.1.2 Market size and forecast, by By Indications

6.2.4.2 Canada

6.2.4.2.1 Market size and forecast, by By Product

6.2.4.2.2 Market size and forecast, by By Indications

6.2.4.3 Mexico

6.2.4.3.1 Market size and forecast, by By Product

6.2.4.3.2 Market size and forecast, by By Indications

6.3 Europe

6.3.1 Key trends and opportunities

6.3.2 Europe Market size and forecast, by By Product

6.3.3 Europe Market size and forecast, by By Indications

6.3.4 Europe Market size and forecast, by country

6.3.4.1 Germany

6.3.4.1.1 Market size and forecast, by By Product

6.3.4.1.2 Market size and forecast, by By Indications

6.3.4.2 France

6.3.4.2.1 Market size and forecast, by By Product

6.3.4.2.2 Market size and forecast, by By Indications

6.3.4.3 U.K.

6.3.4.3.1 Market size and forecast, by By Product

6.3.4.3.2 Market size and forecast, by By Indications

6.3.4.4 Italy

6.3.4.4.1 Market size and forecast, by By Product

6.3.4.4.2 Market size and forecast, by By Indications

6.3.4.5 Spain

6.3.4.5.1 Market size and forecast, by By Product

6.3.4.5.2 Market size and forecast, by By Indications

6.3.4.6 Rest of Europe

6.3.4.6.1 Market size and forecast, by By Product

6.3.4.6.2 Market size and forecast, by By Indications

6.4 Asia-Pacific

6.4.1 Key trends and opportunities

6.4.2 Asia-Pacific Market size and forecast, by By Product

6.4.3 Asia-Pacific Market size and forecast, by By Indications

6.4.4 Asia-Pacific Market size and forecast, by country

6.4.4.1 Japan

6.4.4.1.1 Market size and forecast, by By Product

6.4.4.1.2 Market size and forecast, by By Indications

6.4.4.2 China

6.4.4.2.1 Market size and forecast, by By Product

6.4.4.2.2 Market size and forecast, by By Indications

6.4.4.3 India

6.4.4.3.1 Market size and forecast, by By Product

6.4.4.3.2 Market size and forecast, by By Indications

6.4.4.4 Australia

6.4.4.4.1 Market size and forecast, by By Product

6.4.4.4.2 Market size and forecast, by By Indications

6.4.4.5 South Korea

6.4.4.5.1 Market size and forecast, by By Product

6.4.4.5.2 Market size and forecast, by By Indications

6.4.4.6 Rest of Asia-Pacific

6.4.4.6.1 Market size and forecast, by By Product

6.4.4.6.2 Market size and forecast, by By Indications

6.5 LAMEA

6.5.1 Key trends and opportunities

6.5.2 LAMEA Market size and forecast, by By Product

6.5.3 LAMEA Market size and forecast, by By Indications

6.5.4 LAMEA Market size and forecast, by country

6.5.4.1 Brazil

6.5.4.1.1 Market size and forecast, by By Product

6.5.4.1.2 Market size and forecast, by By Indications

6.5.4.2 Saudi Arabia

6.5.4.2.1 Market size and forecast, by By Product

6.5.4.2.2 Market size and forecast, by By Indications

6.5.4.3 South Africa

6.5.4.3.1 Market size and forecast, by By Product

6.5.4.3.2 Market size and forecast, by By Indications

6.5.4.4 Rest of LAMEA

6.5.4.4.1 Market size and forecast, by By Product

6.5.4.4.2 Market size and forecast, by By Indications

7.1. Introduction

7.2. Top winning strategies

7.3. Product Mapping of Top 10 Player

7.4. Competitive Dashboard

7.5. Competitive Heatmap

7.6. Key developments

8.1 ABBOTT LABORATORIES

8.1.1 Company overview

8.1.2 Company snapshot

8.1.3 Operating business segments

8.1.4 Product portfolio

8.1.5 Business performance

8.1.6 Key strategic moves and developments

8.2 BIOTRONIK SE & CO. KG

8.2.1 Company overview

8.2.2 Company snapshot

8.2.3 Operating business segments

8.2.4 Product portfolio

8.2.5 Business performance

8.2.6 Key strategic moves and developments

8.3 COLIBRI HEART VALVE, LLC.

8.3.1 Company overview

8.3.2 Company snapshot

8.3.3 Operating business segments

8.3.4 Product portfolio

8.3.5 Business performance

8.3.6 Key strategic moves and developments

8.4 EDWARDS LIFE SCIENCE CORPORATION

8.4.1 Company overview

8.4.2 Company snapshot

8.4.3 Operating business segments

8.4.4 Product portfolio

8.4.5 Business performance

8.4.6 Key strategic moves and developments

8.5 HLT, INC.

8.5.1 Company overview

8.5.2 Company snapshot

8.5.3 Operating business segments

8.5.4 Product portfolio

8.5.5 Business performance

8.5.6 Key strategic moves and developments

8.6 LIVANOVA PLC

8.6.1 Company overview

8.6.2 Company snapshot

8.6.3 Operating business segments

8.6.4 Product portfolio

8.6.5 Business performance

8.6.6 Key strategic moves and developments

8.7 MEDTRONIC PLC

8.7.1 Company overview

8.7.2 Company snapshot

8.7.3 Operating business segments

8.7.4 Product portfolio

8.7.5 Business performance

8.7.6 Key strategic moves and developments

8.8 NEOVASC INC.

8.8.1 Company overview

8.8.2 Company snapshot

8.8.3 Operating business segments

8.8.4 Product portfolio

8.8.5 Business performance

8.8.6 Key strategic moves and developments

8.9 NEOCHORD INC.

8.9.1 Company overview

8.9.2 Company snapshot

8.9.3 Operating business segments

8.9.4 Product portfolio

8.9.5 Business performance

8.9.6 Key strategic moves and developments

8.10 CORAMAZE TECHNOLOGIES GMBH.

8.10.1 Company overview

8.10.2 Company snapshot

8.10.3 Operating business segments

8.10.4 Product portfolio

8.10.5 Business performance

8.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY BY PRODUCT, 2020-2030,($MILLION)

TABLE 2. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET REVENUE, FOR MECHANICAL VALVES, BY REGION , 2020-2030,($MILLION)

TABLE 3. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET MECHANICAL VALVES BY COUNTRY, 2020-2030,($MILLION)

TABLE 4. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET REVENUE, FOR BIOPROSTHETIC TISSUE (BIOLOGICAL) VALVES, BY REGION , 2020-2030,($MILLION)

TABLE 5. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BIOPROSTHETIC TISSUE (BIOLOGICAL) VALVES BY COUNTRY, 2020-2030,($MILLION)

TABLE 6. GLOBAL TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY BY INDICATIONS, 2020-2030,($MILLION)

TABLE 7. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET REVENUE, FOR MITRAL VALVE STENOSIS, BY REGION , 2020-2030,($MILLION)

TABLE 8. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET MITRAL VALVE STENOSIS BY COUNTRY, 2020-2030,($MILLION)

TABLE 9. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET REVENUE, FOR MITRAL VALVE PROLAPSE, BY REGION , 2020-2030,($MILLION)

TABLE 10. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET MITRAL VALVE PROLAPSE BY COUNTRY, 2020-2030,($MILLION)

TABLE 11. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET REVENUE, FOR MITRAL VALVE REGURGITATION, BY REGION , 2020-2030,($MILLION)

TABLE 12. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET MITRAL VALVE REGURGITATION BY COUNTRY, 2020-2030,($MILLION)

TABLE 13. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY REGION, 2020-2030,($MILLION)

TABLE 14. NORTH AMERICA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY BY PRODUCT, 2020-2030,($MILLION)

TABLE 15. NORTH AMERICA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY BY INDICATIONS, 2020-2030,($MILLION)

TABLE 16. NORTH AMERICA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 17. U.S. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 18. U.S. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 19. CANADA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 20. CANADA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 21. MEXICO TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 22. MEXICO TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 23. EUROPE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY BY PRODUCT, 2020-2030,($MILLION)

TABLE 24. EUROPE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY BY INDICATIONS, 2020-2030,($MILLION)

TABLE 25. EUROPE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 26. GERMANY TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 27. GERMANY TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 28. FRANCE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 29. FRANCE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 30. U.K. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 31. U.K. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 32. ITALY TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 33. ITALY TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 34. SPAIN TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 35. SPAIN TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 36. REST OF EUROPE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 37. REST OF EUROPE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 38. ASIA-PACIFIC TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY BY PRODUCT, 2020-2030,($MILLION)

TABLE 39. ASIA-PACIFIC TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY BY INDICATIONS, 2020-2030,($MILLION)

TABLE 40. ASIA-PACIFIC TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 41. JAPAN TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 42. JAPAN TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 43. CHINA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 44. CHINA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 45. INDIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 46. INDIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 47. AUSTRALIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 48. AUSTRALIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 49. SOUTH KOREA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 50. SOUTH KOREA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 51. REST OF ASIA-PACIFIC TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 52. REST OF ASIA-PACIFIC TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 53. LAMEA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY BY PRODUCT, 2020-2030,($MILLION)

TABLE 54. LAMEA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY BY INDICATIONS, 2020-2030,($MILLION)

TABLE 55. LAMEA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 56. BRAZIL TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 57. BRAZIL TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 58. SAUDI ARABIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 59. SAUDI ARABIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 60. SOUTH AFRICA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 61. SOUTH AFRICA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 62. REST OF LAMEA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 63. REST OF LAMEA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY BY INDICATIONS 2020-2030,($MILLION)

TABLE 64.ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 65.ABBOTT LABORATORIES: OPERATING SEGMENTS

TABLE 66.ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 67.ABBOTT LABORATORIES: NET SALES,

TABLE 68.ABBOTT LABORATORIES: KEY STRATERGIES

TABLE 69.BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT

TABLE 70.BIOTRONIK SE & CO. KG: OPERATING SEGMENTS

TABLE 71.BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO

TABLE 72.BIOTRONIK SE & CO. KG: NET SALES,

TABLE 73.BIOTRONIK SE & CO. KG: KEY STRATERGIES

TABLE 74.COLIBRI HEART VALVE, LLC.: COMPANY SNAPSHOT

TABLE 75.COLIBRI HEART VALVE, LLC.: OPERATING SEGMENTS

TABLE 76.COLIBRI HEART VALVE, LLC.: PRODUCT PORTFOLIO

TABLE 77.COLIBRI HEART VALVE, LLC.: NET SALES,

TABLE 78.COLIBRI HEART VALVE, LLC.: KEY STRATERGIES

TABLE 79.EDWARDS LIFE SCIENCE CORPORATION: COMPANY SNAPSHOT

TABLE 80.EDWARDS LIFE SCIENCE CORPORATION: OPERATING SEGMENTS

TABLE 81.EDWARDS LIFE SCIENCE CORPORATION: PRODUCT PORTFOLIO

TABLE 82.EDWARDS LIFE SCIENCE CORPORATION: NET SALES,

TABLE 83.EDWARDS LIFE SCIENCE CORPORATION: KEY STRATERGIES

TABLE 84.HLT, INC.: COMPANY SNAPSHOT

TABLE 85.HLT, INC.: OPERATING SEGMENTS

TABLE 86.HLT, INC.: PRODUCT PORTFOLIO

TABLE 87.HLT, INC.: NET SALES,

TABLE 88.HLT, INC.: KEY STRATERGIES

TABLE 89.LIVANOVA PLC: COMPANY SNAPSHOT

TABLE 90.LIVANOVA PLC: OPERATING SEGMENTS

TABLE 91.LIVANOVA PLC: PRODUCT PORTFOLIO

TABLE 92.LIVANOVA PLC: NET SALES,

TABLE 93.LIVANOVA PLC: KEY STRATERGIES

TABLE 94.MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 95.MEDTRONIC PLC: OPERATING SEGMENTS

TABLE 96.MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 97.MEDTRONIC PLC: NET SALES,

TABLE 98.MEDTRONIC PLC: KEY STRATERGIES

TABLE 99.NEOVASC INC.: COMPANY SNAPSHOT

TABLE 100.NEOVASC INC.: OPERATING SEGMENTS

TABLE 101.NEOVASC INC.: PRODUCT PORTFOLIO

TABLE 102.NEOVASC INC.: NET SALES,

TABLE 103.NEOVASC INC.: KEY STRATERGIES

TABLE 104.NEOCHORD INC.: COMPANY SNAPSHOT

TABLE 105.NEOCHORD INC.: OPERATING SEGMENTS

TABLE 106.NEOCHORD INC.: PRODUCT PORTFOLIO

TABLE 107.NEOCHORD INC.: NET SALES,

TABLE 108.NEOCHORD INC.: KEY STRATERGIES

TABLE 109.CORAMAZE TECHNOLOGIES GMBH.: COMPANY SNAPSHOT

TABLE 110.CORAMAZE TECHNOLOGIES GMBH.: OPERATING SEGMENTS

TABLE 111.CORAMAZE TECHNOLOGIES GMBH.: PRODUCT PORTFOLIO

TABLE 112.CORAMAZE TECHNOLOGIES GMBH.: NET SALES,

TABLE 113.CORAMAZE TECHNOLOGIES GMBH.: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET SEGMENTATION

FIGURE 2.TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030

FIGURE 3.TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 11.TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,BY BY PRODUCT,2020(%)

FIGURE 12.COMPARATIVE SHARE ANALYSIS OF MECHANICAL VALVES TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF BIOPROSTHETIC TISSUE (BIOLOGICAL) VALVES TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030(%)

FIGURE 14.TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,BY BY INDICATIONS,2020(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF MITRAL VALVE STENOSIS TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF MITRAL VALVE PROLAPSE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MITRAL VALVE REGURGITATION TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030(%)

FIGURE 18.TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY REGION,2020

FIGURE 19.U.S. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 20.CANADA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 21.MEXICO TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 22.GERMANY TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 23.FRANCE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 24.U.K. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 25.ITALY TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 26.SPAIN TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 27.REST OF EUROPE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 28.JAPAN TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 29.CHINA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 30.INDIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 31.AUSTRALIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 32.SOUTH KOREA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 33.REST OF ASIA-PACIFIC TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 34.BRAZIL TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 35.SAUDI ARABIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 36.SOUTH AFRICA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 37.REST OF LAMEA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)

FIGURE 38. TOP WINNING STRATEGIES, BY YEAR

FIGURE 39. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 40. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 41.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 42.COMPETITIVE DASHBOARD

FIGURE 43.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 44.ABBOTT LABORATORIES.: NET SALES ,($MILLION)

FIGURE 45.BIOTRONIK SE & CO. KG.: NET SALES ,($MILLION)

FIGURE 46.COLIBRI HEART VALVE, LLC..: NET SALES ,($MILLION)

FIGURE 47.EDWARDS LIFE SCIENCE CORPORATION.: NET SALES ,($MILLION)

FIGURE 48.HLT, INC..: NET SALES ,($MILLION)

FIGURE 49.LIVANOVA PLC.: NET SALES ,($MILLION)

FIGURE 50.MEDTRONIC PLC.: NET SALES ,($MILLION)

FIGURE 51.NEOVASC INC..: NET SALES ,($MILLION)

FIGURE 52.NEOCHORD INC..: NET SALES ,($MILLION)

FIGURE 53.CORAMAZE TECHNOLOGIES GMBH..: NET SALES ,($MILLION